Prescription Drug User Fee Act : Structure and Reauthorization Issues.
Reviews the Prescription Drug User Fee Act (PDUFA) of 1992, which authorizes FDA to impose drug approval application fees on drug manufacturers to fund new drug and biologic product safety review activities. Examines implementation of PDUFA, and discusses reauthorization issues.
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2002.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Internet
Connect to the full text of this electronic bookAvailable Online
| Call Number: |
CRS-2002-DSP-0044 |
|
|---|---|---|
| Call Number | Status | Get It |
| CRS-2002-DSP-0044 | Available | |